Cue biopharma to present corporate update at the upcoming btig virtual biotechnology conference

Cambridge, mass., aug. 03, 2021 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells directly within the patient's body, announced today that it will participate in a fireside chat at the btig virtual biotechnology conference being held august 9-10 2021.
CUE Ratings Summary
CUE Quant Ranking